Exercise during CHemotherapy for Recurrent Ovarian cancer (ECHO-R)

Not Applicable

Recruiting

• Conditions: Recurrent Ovarian Cancer; Cancer - Ovarian and primary peritoneal

• Registration Number: ACTRN12621000042842
• Lead Sponsor: Griffith University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-01-18
• Last Update Posted: 27 February 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 80

Inclusion Criteria

Women with recurrent ovarian, peritoneal or fallopian tube cancer of all types (including epithelial, germ cell, stromal, granulosa cell) and a platinum-free interval of at least 6 months (platinum-sensitive disease)
2. Scheduled to receive, or currently receiving, chemotherapy (of any type).
3. Age 18 years or over
4. Willing and able to comply with all study requirements, including the exercise intervention, timing and nature of required assessments (note: face to face assessment is dependant on factors including timing and location, and does not constitute an exclusion criteria).
5. Sufficiently fluent in English to fully participate in data collection requirements and comprehend intervention requirements
6. Signed written informed consent

Exclusion Criteria

Serious medical or psychiatric conditions that might limit the ability of the patient to comply with the protocol.
NOTE: Since exercise safety has been demonstrated in a range of chronic disease settings such as cardiovascular disease, osteoarthritis and stroke, and the intervention is tailored to each woman’s capacity, the presence of other co-morbidities will NOT preclude participation if all other eligibility criteria are met.

Study & Design

• Study Type: Interventional
• Study Design: Not specified